{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 464384589
<!-- Monoclonal antibody data -->
| type = mab
| mab_type = mab
| source = zu/o
| target = [[CD154]]
<!-- Clinical data -->
| tradename = Antova
| pregnancy_AU =  
| pregnancy_US =  
| pregnancy_category =  
| legal_AU =  
| legal_CA =  
| legal_UK =  
| legal_US =  
| legal_status =  
| routes_of_administration =  
<!-- Pharmacokinetic data -->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!-- Identifiers -->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 220651-94-5
| ATC_prefix = none
| ATC_suffix =  
| PubChem =  
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
<!-- Chemical data -->
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
| chemical_formula =  
| molecular_weight =  
}}
'''Ruplizumab''' (trade name '''Antova''') is a [[humanized monoclonal antibody]] intended for the treatment of [[rheumatic disease]]s like [[systemic lupus erythematosus]] and [[lupus nephritis]]. A study showed that the drug was associated with life-threatening [[thromboembolism]]s,<ref>{{cite journal|pmid=15046525|year=2004|last1=Liossis|first1=SN|last2=Sfikakis|title=Costimulation blockade in the treatment of rheumatic diseases|volume=18|issue=2|pages=95–102|journal=BioDrugs|first2=PP|doi=10.2165/00063030-200418020-00003}}</ref> while another study only found [[thrombocytopenia]].<ref>{{cite journal|doi=10.1093/rheumatology/kei118|pmid=16188945|year=2006|last1=Nakamura|first1=M|last2=Tanaka|first2=Y|last3=Satoh|first3=T|last4=Kawai|first4=M|last5=Hirakata|first5=M|last6=Kaburaki|first6=J|last7=Kawakami|first7=Y|last8=Ikeda|first8=Y|last9=Kuwana|first9=M|title=Autoantibody to CD40 ligand in systemic lupus erythematosus: association with thrombocytopenia but not thromboembolism|volume=45|issue=2|pages=150–6|journal=Rheumatology (Oxford, England)}}</ref>

==References==
{{reflist}}

{{immunosuppressants}}
{{Monoclonals for immune system}}

[[Category:Monoclonal antibodies]]


{{monoclonal-antibody-stub}}
{{antineoplastic-drug-stub}}